Full Access with Signal8 Pro, $49/mo billed annually.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 9.30M shares outstanding
eXoZymes, Inc. operates as a synthetic biochemical company in the United States.
The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds.
Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion.
The company was founded in 2014 and is headquartered in Monrovia, California.
Michael Heltzen
President & Chief Executive Officer
Mr. Hayat
Chairman and President
Damien A. Perriman
Chief Commercial Officer
Tyler Korman
Co-Founder & Chief Scientific Officer
Employees
31
Country
US
Sector
Healthcare
Website
exozymes.com
Loading congressional disclosures…
based on 9.30M shares outstanding
30d Avg
7.83K
60d Avg
6.66K
90d Avg
6.81K